These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25542867)

  • 1. [Not Available].
    Rivero A
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():1. PubMed ID: 25542867
    [No Abstract]   [Full Text] [Related]  

  • 2. ART regimen protects children from malaria.
    BMJ; 2012 Dec; 345():e8214. PubMed ID: 23207506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of lopinavir/ritonavir monotherapy].
    Gasol Boncompte M; Padullés Zamora N; Comas Sugranyes M; Jódar Masanés R
    Farm Hosp; 2012; 36(6):561. PubMed ID: 23461460
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protease inhibitor Kaletra (Lopinavir/Ritonavir): significance and role in antiretroviral therapy of HIV infection and AIDS].
    Galegov GA
    Antibiot Khimioter; 2007; 52(1-2):42-5. PubMed ID: 18461809
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of initial antiretroviral therapy based on lopinavir/ritonavir plus 2 nucleoside/nucleotide analogs in patients with human immunodeficiency virus type 1 infection].
    Zamora L; Gatell JM
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():2-6. PubMed ID: 25542868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection.
    Schenone E; Di Biagio A; Parisini A; Bruzzone B; Sticchi L; Calzi A; Nicco E; Secondo G; Viscoli C
    J Chemother; 2012 Feb; 24(1):56-8. PubMed ID: 22546725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial therapy for HIV: can less be more?
    Sax PE
    Lancet Infect Dis; 2014 Jul; 14(7):535-7. PubMed ID: 24783987
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lopinavir/ritonavir in new simplification strategies in antiretroviral therapy].
    Sebastián Mde L; Pardo OB; Ortega FP
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():12-7. PubMed ID: 25542870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lopinavir/ritonavir in human immunodeficiency virus-infected women].
    Téllez MJ
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():22-5. PubMed ID: 25542872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to simplified HIV treatment in low-resource settings.
    Moreira J
    Lancet Infect Dis; 2014 Dec; 14(12):1178-9. PubMed ID: 25455981
    [No Abstract]   [Full Text] [Related]  

  • 11. Lopinavir/ritonavir.
    Porche DJ
    J Assoc Nurses AIDS Care; 2001; 12(2):101-4. PubMed ID: 11296724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lopinavir/ritonavir. (Kaletra).
    Res Initiat Treat Action; 2000 Dec; 6(4):16-8. PubMed ID: 11708169
    [No Abstract]   [Full Text] [Related]  

  • 13. Nevirapine-based therapy after suppression: can we switch?
    Nachman S; McIntyre J
    Lancet Infect Dis; 2012 Jul; 12(7):498-9. PubMed ID: 22424721
    [No Abstract]   [Full Text] [Related]  

  • 14. Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment.
    Khaykin P; Kotzerke P; Stephan C; Nisius G; Bickel M; Haberl A; Stürmer M; Kurowski M; Brodt R; von Hentig N
    Ther Drug Monit; 2014 Apr; 36(2):192-201. PubMed ID: 24632753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Positioning of lopinavir/ritonavir in antiretroviral treatment schemes].
    Camacho Á; Rivero A
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():31-4. PubMed ID: 25542874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lopinavir/ritonavir in new initial antiretroviral treatment strategies].
    Rolón MJ; Figueroa MI; Sued O; Cahn P
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():7-11. PubMed ID: 25542869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kaletra (lopinavir/ritonavir--a new HIV protease inhibitor].
    Ershov FI; Kas'ianova NV; Vasil'ev AN
    Antibiot Khimioter; 2002; 47(11):27-9. PubMed ID: 12698577
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial.
    Cahn P; Andrade-Villanueva J; Arribas JR; Gatell JM; Lama JR; Norton M; Patterson P; Sierra Madero J; Sued O; Figueroa MI; Rolon MJ;
    Lancet Infect Dis; 2014 Jul; 14(7):572-80. PubMed ID: 24783988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Challenges of lopinavir/ritonavir in the chronicity of human immunodeficiency virus infection].
    Aguirrebengoa K
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():26-30. PubMed ID: 25542873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A king in the CASTLE? Optimum initial HIV protease inhibitor.
    Torti C; Frank I
    Lancet; 2008 Aug; 372(9639):604-6. PubMed ID: 18722849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.